2015 Annual Meeting | Infectious, Paraneoplastic, and Autoimmune Encephalopathies: Advances in Clinical Diagnosis and Emerging Insights about Pathogenesis
| 01:00 PM - 01:05 PM |
Introduction
|
|
| 01:00 PM - 05:00 PM | Abstract |
001 - Autoimmune Encephalitis in the ICU: Serological Spectrum, Clinical Courses, Complications and Outcomes
Andrew McKeon, MD |
| 01:00 PM - 05:00 PM | Abstract |
002 - Clinical Features, Diagnostic Findings, and Treatment of Adult-Onset Opsoclonus-Myoclonus Syndrome: A Case Series
Pooja S. Raibagkar, MD |
| 01:00 PM - 05:00 PM | Abstract |
003 - Gait Disturbance as the Initial Presenting Symptom in Young Children With Anti-NMDA Receptor (Anti-NMDAR) Encephalitis: A Case Series
Anusha Yeshokumar, MD |
| 01:00 PM - 05:00 PM | Abstract |
004 - Neurological Manifestations of acute Dengue virus infection : a study from tropical country- India
Devashish D. Ruikar, MD |
| 01:00 PM - 05:00 PM | Abstract |
005 - Quantitative Detection of Human Herpesvirus-6 with Digital Droplet PCR in a Patient with Post-Transplant HHV-6 Encephalitis
Bridgette J. Billioux, MD |
| 01:00 PM - 05:00 PM | Abstract |
006 - Activation of HERV-K and response to antiretroviral therapy in patients with HIV infection and motor neuron disease
Bryan Smith, MD |
| 01:00 PM - 05:00 PM | Abstract |
007 - Evaluation of neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis
Johann Sellner, MD, FAAN |
| 01:00 PM - 05:00 PM | Abstract |
008 - Rapidly Progressive Dementia and Myoclonus with Elevated CSF IgG Index in Young Adult Immigrants: Treatable, but Not Always with Immunosuppression
Cheryl A. Jay, MD, FAAN |
| 01:00 PM - 05:00 PM | Abstract |
009 - Role of c-Jun N-terminal kinase (JNK) signaling in varicella zoster virus infection of neurons
Arun Venkatesan, MD, PhD |
| 01:00 PM - 05:00 PM | Abstract |
010 - Spectrum of MOG Autoantibody-Associated Inflammatory Diseases in Pediatric Patients
Mitchell Silver, MD |
| 01:00 PM - 05:00 PM | Abstract |
011 - Risk Factors and Final Diagnoses of Patients first diagnosed as Infectious Acute Disseminated Encephalomyelitis (ADEM): A single-center study
Diederik L. Koelman |
| 01:00 PM - 05:00 PM | Abstract |
012 - Methotrexate Experience in eight Pediatric Patients with Anti-N-methyl-D-aspartate-receptor Encephalitis
Alfredo Ramirez |
| 01:00 PM - 05:00 PM | Abstract |
013 - Autoimmune Cerebellar Ataxia: Treatment Responses and Outcomes in 118 Patients
Amy L. Jones, MD |
| 01:05 PM - 01:35 PM |
Next-Generation Sequencing for Encephalitis Diagnostics: Case Examples
Joseph DeRisi, PhD |
|
| 01:35 PM - 01:40 PM |
Activation of HERV-K and Response to Antiretroviral Therapy in Patients with HIV Infection and Motor Neuron Disease
Bryan Smith, MD |
|
| 01:40 PM - 01:45 PM |
Evaluation of Neurofilament Heavy Chain as a Marker of Neuroaxonal Pathology and Prognosis in Acute Encephalitis
Johann Sellner, MD, FAAN |
|
| 01:45 PM - 01:55 PM |
Audience Q&A
|
|
| 01:55 PM - 02:25 PM |
Chronic Complications of Encephalitis: HIV and Beyond
Felicia Chow, MD |
|
| 02:25 PM - 02:30 PM |
Rapidly Progressive Dementia and Myoclonus with Elevated CSF IgG Index in Young Adult Immigrants: Treatable, but Not Always with Immunosuppression
Cheryl A. Jay, MD, FAAN |
|
| 02:30 PM - 02:35 PM |
Role of c-Jun N-terminal kinase (JNK) Signaling in Varicella Zoster Virus Infection of Neurons
Arun Venkatesan, MD, PhD |
|
| 02:35 PM - 02:45 PM |
Audience Q&A
|
|
| 02:45 PM - 02:55 PM |
Break
|
|
| 02:55 PM - 03:25 PM |
Autoimmune Encephalitis at the Confluence of Neuronal and Glial Autoimmunity
Markus Reindl, PhD |
|
| 03:25 PM - 03:30 PM |
Spectrum of MOG Autoantibody-Associated Inflammatory Diseases in Pediatric Patients
Silvia Tenembaum, MD |
|
| 03:30 PM - 03:35 PM |
Risk Factors and Final Diagnoses of Patients first diagnosed as Infectious Acute Disseminated Encephalomyelitis (ADEM): A single-center study
Diederik L. Koelman |
|
| 03:35 PM - 03:45 PM |
Audience Q&A
|
|
| 03:45 PM - 04:15 PM |
Walking on the Gray Side: When Your Patient Does Not Fit the Model
Francesc R. Graus, MD |
|
| 04:15 PM - 04:20 PM |
Methotrexate Experience in Eight Pediatric Patients with Anti-N-methyl-D-aspartate-receptor Encephalitis
Alfredo Ramirez |
|
| 04:20 PM - 04:25 PM |
Autoimmune Cerebellar Ataxia: Treatment Responses and Outcomes in 118 Patients
Amy L. Jones, MD |
|
| 04:25 PM - 04:35 PM |
Audience Q&A
|
|
| 04:35 PM - 05:00 PM |
Guided Poster Rounds
|
| Michael R. Wilson, MD, FAAN | Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice. |
| Josep O. Dalmau, MD, PhD, FAAN | Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |
| Johann Sellner, MD, FAAN | Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Boehringer, Celgene, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $0-$499 for serving as a Reviewer with Ethics Committtee. |
| Arun Venkatesan, MD, PhD | Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from MSRCF. The institution of Dr. Venkatesan has received research support from U.S. DOD. |
| Amy L. Jones, MD | No disclosure on file |
| Alfredo Ramirez | No disclosure on file |
| Diederik L. Koelman | No disclosure on file |
| Felicia Chow, MD | Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medicolegal consulting. The institution of Dr. Chow has received research support from NIH. |
| Joseph DeRisi, PhD | Joseph DeRisi, PhD has received personal compensation for serving as an employee of Chan Zuckerberg Biohub. Joseph DeRisi, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allen & Co. Joseph DeRisi, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Public Health Company, Inc. Joseph DeRisi, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Delve Bio. Joseph DeRisi, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for VeriPhi Inc. The institution of Joseph DeRisi, PhD has received research support from Chan Zuckerberg Biohub. Joseph DeRisi, PhD has received intellectual property interests from a discovery or technology relating to health care. |
| Markus Reindl, PhD | The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche. |
| Francesc R. Graus, MD | Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care. |
| Cheryl A. Jay, MD, FAAN | No disclosure on file |
| Bryan Smith, MD | Dr. Smith has nothing to disclose. |
| Silvia Tenembaum, MD | Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. . |
| Sean J. Pittock, MD, FAAN | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Eelco F. Wijdicks, MD, FAAN | Dr. Wijdicks has received publishing royalties from a publication relating to health care. |
| Andrew McKeon, MD | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Alejandro A. Rabinstein, MD, FAAN | Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. |
| Bridgette J. Billioux, MD | Dr. Billioux has nothing to disclose. |
| Farrah J. Mateen, MD, PhD, FAAN | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics (Amgen). Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics (Amgen). The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |
| Sara E. Hocker, MD, FAAN | The institution of Dr. Hocker has received research support from Yale University. Dr. Hocker has received publishing royalties from a publication relating to health care. |
| Jeffrey Cohen, MD, PhD, FAAN | No disclosure on file |
| Maria I. Leite, MD | The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK. |
| Tanuja Chitnis, MD, FAAN | Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover. |
| Ildefonso Rodriguez-Leyva, MD, PhD, FAAN | Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Carnot. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly Eli and Company. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Torrent Pharmaceuticals Mexico. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbvie allergan. |
| Sita J. Sattaluri | Dr. Sattaluri has nothing to disclose. |
| Scott D. Eggers, MD | Dr. Eggers has received publishing royalties from a publication relating to health care. |
| Tariq B. Alfahad, MD | No disclosure on file |
| J. E. Ahlskog, MD, PhD | Dr. Ahlskog has received publishing royalties from a publication relating to health care. |
| Joseph R. Berger, MD, FAAN | Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted . |
| Avindra Nath, MD, MBBS, FAAN | The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care. |
| Manoj Mittal, MD | Dr. Mittal has nothing to disclose. |
| Vanda Lennon, MD, PhD | The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care. |
| Ivana Vodopivec, MD | Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche. |
| Lara Zimmermann, MD | Dr. Zimmermann has nothing to disclose. |
| Anusha Yeshokumar, MD | Dr. Yeshokumar has nothing to disclose. |
| Nicholas Davies | No disclosure on file |
| Thy Nguyen, MD | Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received publishing royalties from a publication relating to health care. |
| Elyse J. Singer, MD | The institution of Dr. Singer has received research support from NIH. Dr. Singer has received personal compensation in the range of $1,000,000+ for serving as a Principal investigator/Study section with NIH. |
| Tanya J. Lehky, MD | Dr. Lehky has nothing to disclose. |
| Shirley H. Wray, MD, PhD, FAAN | No disclosure on file |
| Patrick Waters, PhD | Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care. |
| Shamik Bhattacharyya, MD, FAAN | Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. |
| Pooja S. Raibagkar, MD | Dr. Raibagkar has nothing to disclose. |
| Jessica Klein, MD | No disclosure on file |
| Carlos A. Pardo-Villamizar, MD | The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| Olga R. Thon, MD | Dr. Rosenvald Szenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rosenvald Szenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Rosenvald Szenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. |
| Mitchell Silver, MD | Dr. Silver has nothing to disclose. |
| Karen Da Silva, MD | No disclosure on file |
| Kristin W. Baranano, MD, PhD | No disclosure on file |
| Steven Jacobson | Steven Jacobson has nothing to disclose. |
| Devashish D. Ruikar, MD | Dr. Ruikar has nothing to disclose. |